Kidney Transplant Clinical Trials

166 recruitingLast updated: July 17, 2026

There are 166 actively recruiting kidney transplant clinical trials across 40 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, Los Angeles, California, United States, New York, New York, United States. Updated daily from ClinicalTrials.gov.


Kidney Transplant Trials at a Glance

166 actively recruiting trials for kidney transplant are listed on ClinicalTrialsFinder across 6 cities in 40 countries. The largest study group is Not Applicable with 47 trials, with the heaviest enrollment activity in Boston, Los Angeles, and New York. Lead sponsors running kidney transplant studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, National Institute of Allergy and Infectious Diseases (NIAID), and Assistance Publique - Hôpitaux de Paris.

Browse kidney transplant trials by phase

Treatments under study

About Kidney Transplant Clinical Trials

Looking for clinical trials for Kidney Transplant? There are currently 49 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kidney Transplant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kidney Transplant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 166 trials

Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
Genentech, Inc.500 enrolled1 locationNCT01733082
Recruiting
Not Applicable

Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation

Renal transplantKidney TransplantKidney Disease+2 more
University of Gaziantep68 enrolled1 locationNCT07678073
Recruiting
Not Applicable

Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)

Kidney TransplantOverweight or Obese AdultsGlucose Control
University of Kansas Medical Center60 enrolled1 locationNCT06640179
Recruiting
Phase 1

TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation

Living Donor Kidney Transplantation
Stanford University22 enrolled2 locationsNCT03943238
Recruiting
Not Applicable

Parathyroidectomy After Kidney Transplantation

HyperparathyroidismKidney Transplantation Recipients
Aarhus University Hospital85 enrolled1 locationNCT07415421
Recruiting

Immune Registry for BK in Kidney Transplant Recipients

Kidney Transplant; ComplicationsBK Virus Infection
Virginia Commonwealth University60 enrolled1 locationNCT06538961
Recruiting

Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection

Antibody-mediated Rejection in Kidney Transplant
Centre Hospitalier Universitaire de Besancon31 enrolled1 locationNCT07663669
Recruiting
Phase 2Phase 3

A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

Kidney Transplant Rejection
Sanofi526 enrolled26 locationsNCT07412470
Recruiting
Phase 3

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

Kidney TransplantDelayed Graft FunctionDGF
Alexion Pharmaceuticals, Inc.450 enrolled130 locationsNCT06830798
Recruiting
Phase 2

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

Kidney TransplantationAMRAntibody-mediated Rejection+1 more
Alexion Pharmaceuticals, Inc.45 enrolled55 locationsNCT06744647
Recruiting

Alloreactive Memory B Lymphocytes and Anti-HLA Sensitization

Kidney Transplant
University Hospital, Rouen51 enrolled1 locationNCT07011238
Recruiting
Not Applicable

Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation

Intraoperative hypotensionKidney TransplantDelayed Graft Function
Beijing Friendship Hospital150 enrolled1 locationNCT06855758
Recruiting

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Obese PatientsComorbiditiesDialysis+1 more
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT04748770
Recruiting
Phase 2

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

HypophosphatemiaKidney Transplantation
Stanford University90 enrolled1 locationNCT06824454
Recruiting
Phase 3

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Cytomegalovirus InfectionsKidney Transplant InfectionPancreas Transplant
University of Wisconsin, Madison90 enrolled1 locationNCT06407232
Recruiting

Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA

Kidney Transplant Rejection
Virginia Commonwealth University50 enrolled1 locationNCT07415876
Recruiting
Phase 3

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Kidney Transplant Failure and RejectionBK ViremiaKidney Transplant Infection
The University of Queensland280 enrolled13 locationsNCT05325008
Recruiting
Not Applicable

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

ObesityKidney Transplant; Complications
Virginia Commonwealth University30 enrolled1 locationNCT06688825
Recruiting
Early Phase 1

Tolerance Through Mixed Chimerism (Sip-Tego)

Kidney FailureTransplant Recipient (Kidney)Immunosuppresion+2 more
Tatsuo Kawai, MD, PhD12 enrolled1 locationNCT06972069
Recruiting
Phase 4

Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

Acute Respiratory FailureKidney Transplant RecipientsSepsis and septic shock+1 more
University Hospital, Strasbourg, France212 enrolled1 locationNCT06881927